Clinical Trials Browser

Phase 2/3 × eltrombopag × Clear all

NCT01428635 2023-09-26

Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy

Phase 2/3 Completed

21 enrolled 10 charts

Classical hematologyMyeloidOther hematologic neoplasm

Blast Crisis, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Primary Myelofibrosis

NCT03701217 2018-10-09

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Phase 2/3 Unknown

Classical hematologyOther hematologic neoplasm

Thrombocytopenia, Leukemia, Myeloid, Acute